Semiquantitative Analysis of Epstein-Barr Virus DNA by Polymerase Chain Reaction in Clinical Samples of Lymphoproliferative Disorders

  • Hans Knecht
  • Roland Sahli
  • David J. L. Joske
  • Edith Bachmann
  • Fedor Bachmann
  • Daniel Hayoz
  • Bernhard F. Odermatt
  • Phil Shaw
Part of the Frontiers of Virology book series (FRVIROLOGY, volume 1)


Epstein-Barr virus (EBV) DNA was detected and semiquantitatively analyzed in clinical samples from patients with Hodgkin’s disease (HD), angioim-munoblastic lymphadenopathy (AILD), hairy cell leukemia (HCL), T-lymphoblastic lymphoma (TLL), familial gastric lymphoma, lymphocytic/ mixed thymoma, and reactive lymph node hyperplasia (HR). High numbers of viral DNA copies were detected in HD and AILD, whereas no or very few viral DNA copies were found in HCL and thymoma. One case of TLL and two cases of HR contained relatively high numbers of EBV DNA copies. In the case of TLL, the viral genomes probably originated from accessory B cells. The high amount of EBV DNA identified in the HD and AILD cases is not associated with the Bam W/Bam Z rearrangement known to disrupt viral latency. Technical details of amplification, oligonucleotide hybridization, and semiquantitative EBV DNA analysis are described. A sensitive detection system of the Bam W/Bam Z rearrangement is also presented.


Hairy Cell Leukemia Namalwa Cell Specific Amplification Product Angioimmunoblastic Lymphadenopathy Covalently Close Circular 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anagnostopoulos I, Herbst H, Niedobitek G, Stein H (1989) Demonstration of monoclonal EBV genomes in Hodgkin’s disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 74:810–816PubMedGoogle Scholar
  2. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Séguin C, Tuffnell PS, Barrell BG (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207–211PubMedCrossRefGoogle Scholar
  3. Bankier AT, Deininger PL, Satchwell SC, Baer R, Farrell PJ, Barrell GB (1983) DNA sequence analysis of the EcoRI Dhet fragment of B95-8 Epstein-Barr virus containing the terminal repeat sequences. Mol Biol Med 1:425–445PubMedGoogle Scholar
  4. Cheung A, Kieff E (1982) Long internal direct repeat in Epstein-Barr virus DNA. J Virol 44:286–294PubMedGoogle Scholar
  5. Cleary ML, Nalesnik MA, Shearer WT, Sklar J (1988) Clonal analysis of transplant associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 72:349–352PubMedGoogle Scholar
  6. Countryman J, Miller G (1985) Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci USA 82:4085–4089PubMedCrossRefGoogle Scholar
  7. Countryman J, Jenson H, Scibl R, Wolf H, Miller G (1987) Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol 61:3672–3679PubMedGoogle Scholar
  8. Delcayre AX, Salas F, Mathur S, Kovats K, Lotz M, Lernhardt W (1991) Epstein Barr virus/complement C3d receptor is an interferon α receptor. EMBO J 10:919–926PubMedGoogle Scholar
  9. Desgranges C, Wolf H, De Thé G, Shanmugaratnam K, Cammoun N, Ellouz R, Klein G, Lennert K, Munoz N, zur Hausen H (1975) Nasopharyngeal carcinoma: X. Presence of Epstein-Barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer 16:7–15PubMedCrossRefGoogle Scholar
  10. Fennewald S, van Santen V, Kieff E (1984) Nucleotide sequence of a mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J Virol 51:411–419PubMedGoogle Scholar
  11. Fingeroth JD, Weiss JJ, Tedder TF, Strominger JL, Biro PA, Fearson DT (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510–4516PubMedCrossRefGoogle Scholar
  12. Fischer A, Blanche S, Le Bidois J, Bordigoni P, Gamier JL, Niaudet P, Morinet F, Le Deist F, Fischer AM, Griscelli C, Hirn M (1991) Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324:1451–1456PubMedCrossRefGoogle Scholar
  13. Frizzera G, Moran EM, Rappaport H (1974) Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet i: 1070–1073CrossRefGoogle Scholar
  14. Henderson A, Ripley S, Heller M, Kieff E (1983) Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc Natl Acad Sci USA 80:1987–1991PubMedCrossRefGoogle Scholar
  15. Herbst N, Niedobitek G, Kneba M, Hummel M, Finn T, Anagnostopoulos I, Bergholz M, Krieger G, Stein H (1990) High incidence of Epstein-Barr virus genomes in Hodgkin’s disease. Am J Pathol 137:13–18PubMedGoogle Scholar
  16. Hurley EA, Thorley-Lawson DA (1988) B cell activation and the establishment of Epstein-Barr virus latency. J Exp Med 168:2059–2075PubMedCrossRefGoogle Scholar
  17. Hurley EA, Agger S, McNeil JA, Lawrence JB, Calendar A, Lenoir G, Thorley-Lawson DA (1991) When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J Virol 65:1245–1254PubMedGoogle Scholar
  18. Itakura K, Rossi JJ, Wallace RB (1984) Synthesis and use of synthetic oligonucleotides. Annu Rev Biochem 53:323–356PubMedCrossRefGoogle Scholar
  19. Jenson HB, Miller G (1988) Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency. Virology 165:549–564PubMedCrossRefGoogle Scholar
  20. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J (1988) T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318:733–741PubMedCrossRefGoogle Scholar
  21. Katz BZ, Raab-Traub N, Miller G (1989) Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative disorders. J Infect Dis 160:589–598PubMedCrossRefGoogle Scholar
  22. Katzenstein AL, Peiper S (1990) Detection of Epstein-Barr virus genomes in lymphomatoid granulomatosis: analysis of 29 cases using the polymerase chain reaction technique. Mod Pathol 3:435–441PubMedGoogle Scholar
  23. Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F, Tawa A, Hirai K (1989) CD-3 negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84:51–55PubMedCrossRefGoogle Scholar
  24. Kieff E, Liebowitz D (1991) Epstein-Barr virus and its replication. In: Fields BN, Knipe DM (eds) Fundamental virology, 2nd edn. Raven, New York, pp 897–928Google Scholar
  25. Kikuta H, Taguchi Y, Tomizawa K, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, Koizumi S, Osato T, Kobayashi I, Hamada I, Hirai K (1988) Epstein-Barr virus genome-positive lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333:455–457PubMedCrossRefGoogle Scholar
  26. Knecht H (1989) Angioimmunoblastic lymphadenopathy; ten years’ experience and state of current knowledge. Semin Hematol 26:208–215PubMedGoogle Scholar
  27. Knecht H, Sahli R, Shaw P, Meyer C, Bachmann E, Odermatt BF, Bachmann F (1990) Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy. Br J Haematol 75:610–614PubMedCrossRefGoogle Scholar
  28. Knecht H, Odermatt BF, Bachmann E, Teixeira S, Sahli R, Hayoz D, Heitz P, Bachmann F (1991) Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin’s disease without genomic evidence of B or T cell clonality. Blood 78:760–767PubMedGoogle Scholar
  29. Lawrence JB, Villnave CA, Singer RH (1988) Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell 52:51–61PubMedCrossRefGoogle Scholar
  30. Lenoir GM, Bornkamm GW (1987) Burkitt’s lymphoma, a human cancer model for the study of the multistep development of cancer: proposal of a new scenario. In: Klein G (ed) Advances in viral oncology, vol 7. Raven, New York, pp 173–206Google Scholar
  31. Lindahl T, Adams A, Byursell G, Bornkamm GW, Kaschka-Dierich C, Jehn U (1976) Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J Mol Biol 102:511–530PubMedCrossRefGoogle Scholar
  32. Lipford EH, Smith HR, Pittaluga S, Jaffe ES, Steinberg AD, Cossman J (1987) Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma. J Clin Invest 79:637–642PubMedCrossRefGoogle Scholar
  33. Matsuo T, Heller M, Petti L, O’Shiro E, Kieff E (1984) Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. Science 226:1322–1324PubMedCrossRefGoogle Scholar
  34. McGuire LJ, Huang DP, Teoh R, Arnold M, Wong K, Lee JCK (1988) Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. Am J Pathol 131:385–390PubMedGoogle Scholar
  35. Patton DF, Shirley P, Raab-Traub N, Resnick L, Sixbey JW (1990) Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia. J Virol 64:397–400PubMedGoogle Scholar
  36. Pfitzner AJ, Strominger JL, Speck SH (1987) Characterization of a cDNA clone corresponding to a transcript from the Epstein-Barr virus Bam HI M fragment: evidence of overlapping mRNAs. J Virol 61:2943–2946PubMedGoogle Scholar
  37. Pritchett R, Pedersen M, Kieff E (1976) Complexity of EBV homologous DNA in continuous lymphoblastoid cell lines. Virology 74:227–231CrossRefGoogle Scholar
  38. Raab-Traub N, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883–889PubMedCrossRefGoogle Scholar
  39. Reymond CD (1987) A rapid method for the preparation of multiple samples of eucaryotic DNA, Nucleic Acids Res 15:8118PubMedCrossRefGoogle Scholar
  40. Rowe M, Gregory C (1989) Epstein-Barr virus and Burkitt’s lymphoma. In: Klein G (ed) Advances in viral oncology, vol. 8. Raven, New York, pp 237–259Google Scholar
  41. Rowe M, Evans HS, Young LS, Hennessy K, Kieff E, Rickinson AB (1987) Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J Gen Virol 68:1575–1586PubMedCrossRefGoogle Scholar
  42. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491PubMedCrossRefGoogle Scholar
  43. Saito I, Servenius B, Compton T, Fox RI (1989) Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren’s syndrome. J Exp Med 169:2191–2198PubMedCrossRefGoogle Scholar
  44. Staal SP, Ambinder R, Beschorner WE, Hayward GS, Mann R (1989) A survey of Epstein-Barr virus DNA in lymphoid tissue. Am J Clin Pathol 91:1–5PubMedGoogle Scholar
  45. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, Cheng AL, Kadin ME, Chen JY (1991) Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 77:799–808PubMedGoogle Scholar
  46. Sudgen B, Phelps M, Domoradzki J (1979) Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol 31:590–595Google Scholar
  47. Tanner J, Weis J, Fearon D, Whang Y, Kieff E (1987) Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates absorption, capping, and endocytosis. Cell 50:203–213PubMedCrossRefGoogle Scholar
  48. Thore A, Dosch HM, Gelfand EW (1979) Expression and modulation of C3 receptors during early T-cell ontogeny. Cell Immunol 45:157–159CrossRefGoogle Scholar
  49. Thorley-Lawson DA (1988) Basic virological aspects of Epstein-Barr virus infection. Semin Hematol 25:247–260PubMedGoogle Scholar
  50. Tugwood JD, Law WH, O SK, Tsao SY, Martin WM, Shiu W, Desgranges C, Jones PH, Arrand JR (1987) Epstein-Barr virus specific transscription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients. J Gen Virol 68:1081–1091PubMedCrossRefGoogle Scholar
  51. Vos JMH, Wauthier EL, Hanawalt PC (1989) DNA damage stimulates human cell transformation by integrative but not episomal Epstein-Barr virus-derived plasmid. Mol Carcinog 2:237–244PubMedCrossRefGoogle Scholar
  52. Wallace LE, Murray RJ (1989) Immunological aspects of the Epstein-Barr virus system. In: Klein G (ed) Advances in viral oncology, vol 8. Raven, New York, pp 219–236Google Scholar
  53. Wallace LE, Rickinson AB, Rowe M, Epstein MA (1982) Epstein-Barr virus specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature 297:413–415PubMedCrossRefGoogle Scholar
  54. Weiss LM, Movahed LA, Warnke RA, Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med 320:502–506PubMedCrossRefGoogle Scholar
  55. White Jr AC, Katz BZ, Silbert JA (1989) Association of Epstein-Barr virus with an angioimmunoblastic lymphadenopathy-like lymphoproliferative syndrome. Yale J Biol Med 62:263–269PubMedGoogle Scholar
  56. Wolf BC, Martin AW, Neiman RS, Janckila AJ, Yam LT, Caracansi A, Leav BA, Winpenny R, Schultz DS, Wolfe HJ (1990) The detection of Epstein-Barr virus in hairy cell leukemia cells by in situ hybridization. Am J Pathol 136:717–723PubMedGoogle Scholar
  57. Yoneda N, Tatsumi E, Kawanishi M, Teshigawara K, Masuda S, Yamamura Y, Inui A, Yoshino G, Oimomi M, Baba S, Yamaguchi N (1990) Detection of Epstein Barr virus genome in benign polyclonal proliferative T cells of a young male patient. Blood 76:172–177PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • Hans Knecht
    • 1
  • Roland Sahli
    • 2
  • David J. L. Joske
    • 1
  • Edith Bachmann
    • 1
  • Fedor Bachmann
    • 1
  • Daniel Hayoz
    • 1
  • Bernhard F. Odermatt
    • 4
  • Phil Shaw
    • 3
  1. 1.Department of Medicine and InstitutesUniversity Hospital CHUVLausanneSwitzerland
  2. 2.Department of Medicine and Institutes of MicrobiologyUniversity Hospital CHUVLausanneSwitzerland
  3. 3.Department of Medicine and Institutes of PathologyUniversity Hospital CHUVLausanneSwitzerland
  4. 4.Department of PathologyUniversity HospitalZürichSwitzerland

Personalised recommendations